Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S193000, C546S194000
Reexamination Certificate
active
10753057
ABSTRACT:
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety.
REFERENCES:
patent: 5459151 (1995-10-01), Lombardo et al.
patent: 6441000 (2002-08-01), Gibson et al.
patent: 6720324 (2004-04-01), Marzabadi et al.
patent: 6727264 (2004-04-01), Marzabadi et al.
patent: 2003/0077701 (2003-04-01), Salon et al.
patent: 2004/0038855 (2004-02-01), Salon et al.
patent: WO 00/021934 (2000-04-01), None
patent: WO 02/02744 (2002-01-01), None
patent: WO-02/6245 (2002-01-01), None
patent: WO 02/030927 (2002-04-01), None
patent: WO-02/94799 (2002-11-01), None
patent: WO-03/4027 (2003-01-01), None
patent: WO-04/4714 (2004-01-01), None
patent: WO-04/5257 (2004-01-01), None
Connoly et al. “Preparation of 2-aminopyridines . . . ” CA 132:279120 (2000).
Chen et al. “Preparation of substituted 3,4-dihydro-4H . . . ” CA 141:123625 (2004).
Lightowler et al. “Anxiolytic like effect . . . ” Ca 121:195817 (1994).
S. Takekawa, et al., “T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist”, Eur. J. Pharmacol. 438(3), (2002) pp. 129-135.
U.S. Appl. No. 10/719,358, Marzabadi et al., filed Nov. 21, 2003, not yet published.
Chen Chien-An
Jiang Yu
Lu Kai
Marzabadi Mohammad R.
Wetzel John M.
Chang Celia
Darby & Darby
H. Lundbeck A/S
LandOfFree
Substituted alkyl amido piperidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted alkyl amido piperidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted alkyl amido piperidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3738926